A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib
Pathology International · 2024-09 · 74 (9) · 546-551
DOI: 10.1111/pin.13464 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology International, online erschienen am 17.07.2024. Verfasst von Hironori Uruga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Lung Neoplasms, Adenocarcinoma of Lung, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Okinaka Memorial Institute for Medical Research.
Abstract (Originalsprache)
Hepatoid adenocarcinoma of the lung is a rare variant of adenocarcinoma. We describe a case of hepatoid adenocarcinoma of the lung that harbored KRAS G12C and responded favorably to sotorasib. A man in his 70s was found to have an abnormality on his chest X‐ray. He underwent right middle lobectomy, and a pathological examination of the surgical specimen showed conventional invasive adenocarcinoma with highly focal hepatoid adenocarcinoma. He received chemoradiotherapy and concurrent radiation, followed by durvalumab for postoperative recurrence. After three doses of durvalumab, he reported feeling short of breath. A computed tomography scan showed emerging broad consolidation in the right lower lobe. Transbronchial lung biopsy specimens from the consolidation showed hepatoid adenocarcinoma harboring KRAS G12C mutation. Therefore, he was started on sotorasib 960 mg daily. Eight days later, a computed tomography scan showed that the area of consolidation had reduced in size. Progressive disease was detected after 42 days of treatment with sotorasib. The patient died 1 month after cessation of sotorasib and 3 months after postoperative recurrence. We have encountered what we believe to be the first case of hepatoid adenocarcinoma of the lung with KRAS G12C mutation that responded favorably to treatment with sotorasib.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Toranomon Hospital, Tokyo, Japan.
- Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
- Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, Japan.
- Department of Pathology, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
- Department of Respiratory Medicine, Tokyo Medical University Hospital, Tokyo, Japan.
- Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.
Förderung
- Okinaka Memorial Institute for Medical Research
Zitieren
APA
Uruga, H., Miyamoto, A., Fujii, T., Okuma, T., Mitsumura, T., Tamaoka, M., & Takazawa, Y. (2024). A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib. Pathology International, 74(9), 546-551. https://doi.org/10.1111/pin.13464
Vancouver
Uruga H, Miyamoto A, Fujii T, Okuma T, Mitsumura T, Tamaoka M, et al. A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib. Pathology International. 2024;74(9):546-551. doi:10.1111/pin.13464
BibTeX
@article{Uruga2024,
author = {Uruga, Hironori and Miyamoto, Atsushi and Fujii, Takeshi and Okuma, Takashi and Mitsumura, Takahiro and Tamaoka, Meiyo and Takazawa, Yutaka},
title = {A case of hepatoid adenocarcinoma of the lung harboring KRAS G12C responded favorably to sotorasib},
journal = {Pathology International},
year = {2024},
volume = {74},
number = {9},
pages = {546--551},
doi = {10.1111/pin.13464}
}
EUVIMED